353
Participants
Start Date
September 1, 2018
Primary Completion Date
June 30, 2021
Study Completion Date
June 30, 2021
Triptolide Wilfordii
In addition to appropriate ART, Triptolide Wilfordii will be given to patients in the experimental group at a dosage of 20mg three times a day per os for 12 months.
Placebo Oral Tablet
In addition to appropriate ART, placebo oral tablets will be given to patients in the experimental group at a dosage of 2 pills three times a day per os for 12 months.
Beijing YouAn Hospital, Capital Medical University, Beijing
Beijing Ditan Hospital, Capital Medical University, Beijing
The Fourth Affiliated Hospital of Harbin Medical University, Harbin
Xixi Hospital of Hangzhou, Hangzhou
Mengchao Hepatobiliary Hospital of Fujian Medical University, Fuzhou
The Sixth People's Hospital of Zhengzhou, Zhengzhou
The Eighth People's Hospital of Guangzhou, Guangzhou
Peking Union Medical College Hospital
OTHER